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MANUSCRIPT TITLE 1 
Perioperative Practices Concerning Sleeve Gastrectomy – a Survey of 863 Surgeons 2 
with a Cumulative Experience of 520,230 Procedures 3 
ABSTRACT 4 
Background 5 
Sleeve Gastrectomy (SG) is the most commonly performed bariatric procedure worldwide. 6 
There is currently no scientific study aimed at understanding variations in practices 7 
concerning this procedure. The aim of this study was to study the global variations in 8 
perioperative practices concerning SG. 9 
Methods 10 
A 37-item questionnaire-based survey was conducted to capture the perioperative practices of 11 
the global community of bariatric surgeons. Data were analysed using descriptive statistics.  12 
Results 13 
Response of 863 bariatric surgeons from 67 countries with a cumulative experience of 14 
520,230 SGs were recorded.  A total of 689 (80%) and 764 (89%) surgeons listed 13 absolute 15 
and relative contraindications, respectively. 65% (n = 559) surgeons perform routine 16 
preoperative endoscopy and 97% (n=835) routinely use intraoperative orogastric tube for 17 
sizing the resection. A wide variation is observed in the diameter of the tube used. 73% 18 
(n=627) surgeons start dividing the stomach at a distance of 3-5 cm from the pylorus, and 19 
54% (n=467) routinely use staple line reinforcement. Majority (65%, n=565) of surgeons 20 
perform routine intraoperative leak test at the end of the procedure, while 25% (n=218) 21 
surgeons perform a routine contrast study in the early postoperative period. Lifelong 22 
2 
 
multivitamin/mineral, iron, vitamin D, calcium, and vitamin B12 supplementation is 23 
advocated by 66%, 29%, 40%, 38% and 44% surgeons, respectively. 24 
Conclusion 25 
There is a considerable variation in the perioperative practices concerning SG. Data can help 26 



















Sleeve Gastrectomy (SG) is now the most commonly performed bariatric procedure in the 44 
world [1]. It was first performed by Hess in 1988 as a component of biliopancreatic 45 
diversion-duodenal switch (BPD-DS) procedure which was modified from Scopinaro’s 46 
biliopancreatic diversion (BPD) and DeMeester’s duodenal switch (DS) procedure [2-4]. 47 
With the evolution of laparoscopic surgery in the 1990s, Gagner performed the first 48 
laparoscopic SG as a part of BPD-DS in 1999 [5]. In the early part of the 21st century, it was 49 
popularized as a first-step intervention before BPD or gastric bypass in the super obese and 50 
high-risk group of patients [6-7]. Due to the unexpected good results in terms of weight loss 51 
and resolution of comorbidities, coupled with the simplicity of performing the procedure 52 
requiring intervention on only the stomach, SG gained status as a stand-alone bariatric 53 
procedure [8,9].   54 
Despite SG being the most commonly performed procedure worldwide, there is a lack of 55 
agreement amongst surgeons regarding its contraindications, preoperative assessment, 56 
technical aspects of the procedure such as diameter of the orogastric tube to size the sleeve, 57 
distance from the pylorus at the beginning of gastric transection, staple line reinforcement, 58 
intraoperative leak test, and postoperative management [10-12]. 59 
Though there have been previous attempts to build consensus on various aspects of SG 60 
[10,11], these efforts have been hampered somewhat by lack of published scientific data on 61 
global variation in practices concerning this procedure. The objective of this study was to 62 
understand the variations in perioperative practices concerning SG through a survey of global 63 
community of bariatric surgeons on its contraindications, preoperative assessment, 64 
intraoperative technical details and postoperative management. It is expected that 65 
understanding variations in practice scientifically may pave way for focused studies to 66 
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identify best practice in the future. A better understanding of the global variations in practices 67 






















This survey followed the principles of good practice in the conduct and reporting of survey 88 
research as recommended by the EQUATOR network guidelines [13]. A 37-item 89 
questionnaire-based survey (https://www.surveymonkey.co.uk/r/Mahawar) was conducted 90 
encompassing the global community of bariatric and metabolic surgeons. The 37 items in the 91 
questionnaire were formulated by the authors based on the existing controversies surrounding 92 
the management of patients who undergo SG. Eight bariatric surgeons from 5 continents 93 
shared responsibility of circulating the survey within the global bariatric community through 94 
emails, social media and personal interaction. The link to the survey was freely shared on 95 
social and scientific media (FacebookTM, ResearchgateTM, TwitterTM, WhatsappTM and 96 
LinkednTM), and through personal network.  97 
The survey was made live on 02/02/019 and closed for analysis on 29/03/2019. Questions 98 
enquired about the responder’s experience with SG, contraindications, preoperative 99 
investigations, technical details and postoperative management. Full details of the 100 
questionnaire have been provided in Table 1. 101 
Analysis was done using descriptive statistics as numbers (percentage) and bar graphs were 102 










Of the 942 surgeons who responded to the survey, 79 did not perform SG and their responses 111 
were omitted. The remaining 863 surgeons had performed 5,20,230 SGs till the time of 112 
completion of the survey and their responses were included. 113 
Nationality of the respondents 114 
A total of 67 countries were represented in the survey. Table 2 provides the representation of 115 
the respondents in terms of nationality. 116 
Experience of the respondents 117 
Approximately, 12.5% (n=109) surgeons had performed between 1-50 SGs, 13% (n=113) 118 
had performed between 51-100 SGs, 38% (n=332) had performed 101-500 SGs while 30% 119 
(n=255) surgeons had performed more than 500 SGs at the time of completion of the survey. 120 
The mean experience per surgeon of the entire cohort was 603 procedures. 121 
Absolute contraindications of SG 122 
A total of 689 (80%) surgeons listed 13 absolute contraindications to SG, while 106 (12%) 123 
felt there was no absolute contraindication of SG. The list of absolute contraindications to SG 124 
chosen by the participants are enumerated in Table 3. 125 
Relative contraindications of SG 126 
A total of 764 (89%) surgeons listed 13 relative contraindications to SG, while 64 (7.4%) felt 127 
no relative contraindications of SG. Relative contraindications to SG as listed by the 128 
participants are enumerated in Table 4. 129 
Preoperative assessment 130 
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A total of 559 (65%) surgeons reported that they perform routine preoperative Upper Gastro-131 
Intestinal Endoscopy (UGIE) before SG while 275 (32%) did not. A slightly lower number 132 
(n=527; 61%) of surgeons perform routine ultrasound of the abdomen while 330 (38%) did 133 
not.  134 
Intraoperative technical details 135 
Orogastric tube - An overwhelming 97% (n=835) surgeons routinely use an orogastric tube 136 
to size the sleeve. A wide variation was observed in the size of the orogastric tube used, 137 
which has been provided in Figure 1. Size of 36 Fr was used by maximum number of 138 
surgeons (n=344; 40%) 139 
Distance from the pylorus at the beginning of gastric transection - Wide variation was also 140 
observed in the distance from the pylorus at the beginning of gastric transection while 141 
fashioning the sleeve, as enumerated in Figure 2. Most surgeons prefer to begin the gastric 142 
transection at 4-5 cm from pylorus (n=501; 58%) 143 
Intraoperative detection and management of hiatus hernia - Routine hiatal dissection to rule 144 
out occult hiatus hernia was performed by 24% (n=204) surgeons, while 623 (72%) surgeons 145 
did not. Once encountered with a preoperatively or intraoperatively diagnosed diaphragmatic 146 
hernia, posterior crural approximation is preferred by 34% (n=296) surgeons, anterior crural 147 
approximation by 8.2% (n=71) surgeons, while 26% (n=221) surgeons perform anterior or 148 
posterior crural approximation depending on the anatomy. Approximately 29% (n=249) 149 
surgeons do not routinely approximate the diaphragmatic crura in patients with identified 150 
hiatus hernias.   151 
Staple line reinforcement – Approximately 54% (n=467) surgeons routinely use staple line 152 
reinforcement while fashioning the sleeve while 43% (n=369) surgeons do not use routine 153 
staple line reinforcement. 334 surgeons (39%) mentioned that they do not use any 154 
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reinforcement. A total of 502 (58%) surgeons mentioned their choice of staple line 155 
reinforcement and a wide variation was observed in their choices as enumerated in Table 5. 156 
18% (n=154) surgeons routinely anchored the omentum to the sleeve at the end of the 157 
procedure while 77% (n=668) did not. 158 
Clipping of short gastric vessels – 89% (n=771) do not clip the splenic end of short gastric 159 
vessels before dividing it with energy device, while 3.2% (n=28) clip the short gastric vessels 160 
routinely. 61 (7.1%) clip it only when faced with a large vessel.   161 
Intraoperative leak test - 65% (n=565) surgeons perform routine intraoperative leak test at 162 
the end of the procedure, while 11% (n=96) perform routine intraoperative UGIE. 732 (85%) 163 
surgeons mentioned their choice of the leak test method which is enumerated in Table 6. 164 
Use of abdominal drain – Approximately 65% (n=558) surgeons do not use an 165 
intraabdominal drain routinely after SG, 21% (n=180) use it for <48 hours, while 12.5% 166 
(n=108) leave a drain for >48 hours. 167 
Single Incision and Robotic Sleeve Gastrectomy – Approximately 12% (n=105) perform 168 
single incision SG while 10% (n=86) surgeons perform the procedure robotically. 169 
Postoperative management 170 
Water soluble contrast study - 25% (n=218) surgeons perform a routine water-soluble 171 
contrast study in the early postoperative period while 73% (n=629) do not. Oral intake is 172 
encouraged on the day of surgery by 45.5% (n=393) surgeons, on the first day after surgery 173 
by 41% (n=353) surgeons, and on the second day after surgery by 6.4% (n=55) surgeons. A 174 
total of 45 (5.2%) surgeons start oral intake only after confirming the absence of leak on a 175 
water-soluble contrast study. 176 
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Micronutrient supplementation - Lifelong multivitamin/mineral supplements after SG is 177 
recommended by 66% (n=567) surgeons, iron supplements by 29% (n=250) surgeons, 178 
vitamin D supplements by 41% (n=346) surgeons, calcium supplements by 38% (n=324) 179 
surgeons, and vitamin B12 supplements by 44% (n=383) surgeons. 180 
PPI and gallstone prophylaxis – Approximately 79% (n=681) surgeons routinely use PPI 181 
prophylaxis after SG, while only 20% (n=172) use ursodeoxycholic acid for prophylaxis of 182 
gall stones. 183 
Revisional procedure after Sleeve Gastrectomy for further weight loss and resolution of 184 
comorbidities - For further weight loss and resolution of co-morbidities after SG, the 185 
preferred revisional procedure offered to patients is Roux-en-Y gastric bypass (RYGB) by 186 
51% (n=441) surgeons, one anastomosis gastric bypass (OAGB) by 25% (n=217) surgeons, 187 
single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) procedure by 188 
10% (n=87) surgeons, and duodenal switch (DS) by 3.2% (n=28) surgeons, while only 2.2% 189 
(n=19) surgeons prefer to re-sleeve their patients. 190 
Revisional procedure after Sleeve Gastrectomy for gastro-esophageal reflux disease (GERD) 191 
- For patients troubled with symptoms of GERD unresponsive to maximal medical therapy, 192 
the preferred revisional procedure of choice offered is RYGB by 87% (n=752) surgeons. 193 
Other revisional options offered for GERD are OAGB by 64 (7.4%) surgeons, SADI-S by 7 194 








This survey on 863 bariatric and metabolic surgeons from 67 countries with a cumulative 201 
experience of 520,230 SGs is the largest survey of surgical community in scientific literature 202 
aimed to capture the global practices concerning SG and is expected to identify areas of 203 
future research and building of consensus that might help in improving outcomes. 204 
Literature on how SG influences Barrett’s esophagus and GERD is conflicting. Gagner noted 205 
that “SG improves symptoms and reduces reflux in most morbidly obese patietns with 206 
preoperative reflux. [14]”. Genco et al, on the other hand, published a series of 110 patients 207 
and showed an increase GERD symptoms and PPI intake after SG along with newly 208 
diagnosed Barrett’s esophagus occurring in 17.2% of patients at a follow up of 58 months 209 
[15]. In this survey, 79% surgeons believed Barrett’s esophagus to be an absolute 210 
contraindication to SG and 28% believed it to be a relative contraindication. In contrast, only 211 
23% surgeons viewed GERD to be an absolute contraindication while 56% surgeons believed 212 
only severe GERD requiring daily PPI therapy to be an absolute contraindication to SG. This 213 
survey showed that what constitutes as a relative contraindication to one group of surgeons is 214 
an absolute contraindication for another suggesting a lack of clarity due to conflicting 215 
literature on the safety of SG in individual groups of patients. More studies comparing 216 
different procedures are needed for patients with GORD.  217 
The ASMBS guidelines advocates the use of UGIE preoperatively on a selective basis based 218 
on the presence of symptoms [16]. This is in contrast to the observation by another study that 219 
found significant findings relevant for SG (hiatus hernia, esophagitis, Barrett’s esophagus, 220 
esophageal dysplasia) in 23% patients, of whom only half were symptomatic and the authors 221 
concluded that preoperative UGIE was indicated before SG for all patients irrespective of 222 
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symptoms [17]. Once again, significant variation was observed in this survey with only 65% 223 
surgeons advocating routine UGIE before SG. 224 
This survey found wide variation in the diameter of the orogastric tube used to size the 225 
sleeve, even though the majority (40%) of surgeons preferred a size of 36 Fr. The 226 
International Sleeve Gastrectomy Consensus recommends a 32-36 Fr sized orogastric tube 227 
and a distance of 2-6 cm from the pylorus as per their survey based best practice guidelines 228 
[10]. A meta-analysis of 9,991 patients showed reduced leak rate by increasing the diameter 229 
of the bougie (>40 Fr), however, neither the diameter of the bougie nor the distance from 230 
pylorus at the beginning of distal section showed any correlation with excess weight loss 231 
[18]. This is in contrast to a few studies that showed a higher excess weight loss by reducing 232 
the size of the bougie and closing the distance of the first section nearer to the pylorus 233 
[19,20]. Another study showed that increasing the size of the bougie (>38 Fr) was associated 234 
with lower leak rate while increasing the distance of the beginning of gastric transection from 235 
the pylorus was associated with greater weight loss [21]. This survey showed that 82% 236 
surgeons prefer an orogastric tube <40 Fr in diameter while 16% surgeons prefer >40 Fr. 237 
73% surgeons prefer a distance of 3-5 cm from the pylorus at the beginning of gastric 238 
transection, while 1.39% prefer a distance of >6cm. Significant variation among surgeons 239 
with regard to the size of orogastric tube and distance of the beginning of gastric transection 240 
from the pylorus, as demonstrated in this survey, could be due to conflicting literature and 241 
reflects the need for high quality randomized controlled trials on the topic. 242 
The use of reinforcements with the stapling device to construct the sleeve has been a matter 243 
of contextual debate among bariatric and metabolic surgeons, with this survey showing 54% 244 
surgeons who prefer to reinforce the staple line routinely. Of those who use reinforcements 245 
(n=502), 41% prefer to oversew the staple line with running suture, 30% use SeamguardTM 246 
(absorbable polymer membrane), 17% invaginate the staple line with running suture, 15% use 247 
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MedtronicTM reinforced staples, 5.3% use PeristripsTM (bovine pericardial strips) and 4.6% 248 
use fibrin sealant. A systematic review of 30 studies (4,881 patients) and a meta-analysis of 249 
791 patients from 8 randomized controlled trials on staple-line reinforcements in SG showed 250 
no statistical difference in terms of staple line leak and bleeding, though bleeding tended to 251 
reduce with reinforcements [22, 23]. Similar findings were observed by Dapri et al who 252 
compared three techniques – non-reinforcement, absorbable membrane, and staple line 253 
suture. The study found no difference in staple line leak between the three groups but the use 254 
of absorbable membrane reduced bleeding [24]. Contradictory data is obtained from Choi et 255 
al who performed a review of 1345 patients and Gagner et al who analyzed 88 articles with 256 
8,920 patients [25, 26]. Both of these studies found reduced incidence of staple line leak with 257 
reinforcements [25, 26]. A systematic review of 148 studies with 40,653 patients compared 258 
the different types of reinforcements and found absorbable polymer membrane to be superior 259 
to oversewing, fibrin glue, bovine pericardial strips and no reinforcement in the prevention of 260 
staple line leak [27]. 261 
Literature shows no correlation between intraoperative leak test with staple line leaks, with 262 
most leaks known to occur in patients with negative intraoperative leak test [28-30]. Some 263 
authors have in fact described a higher likelihood of staple line leak after intraoperative leak 264 
test [29,30]. Contradictory data is obtained from a review of four studies that suggested 265 
routine use of methylene blue test intraoperatively [31]. Some studies endorse routine use of 266 
leak test using intraoperative endoscopy utilizing air insufflation [32]. Another study on 712 267 
patients showed intraoperative leak test with methylene blue to be a sensitive and effective 268 
method for detecting intraoperative leak during SG with the authors suggesting its routine use 269 
in all cases [33]. However, no correlation was observed in this study with early postoperative 270 
water-soluble contrast study and the authors suggested that the use of routine contrast study 271 
in the postoperative period was not indicated unless clinically indicated in selected patients 272 
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[33]. This survey captured the existing practice of 863 bariatric surgeons and found that 65% 273 
surgeons perform routine intraoperative leak test while only 11% surgeons perform routine 274 
intraoperative endoscopy in SG. Of those who routinely perform intraoperative leak test 275 
(n=732), dilute methylene blue solution is the preferred choice among 63% surgeons, 11.4% 276 
preferred air insufflation using orogastric tube, while 9.4% surgeons prefer to use air 277 
insufflation with an endoscope. In contrast, only 25% surgeons perform a contrast study in 278 
the early postoperative period for detection of staple line leak routinely. 65% surgeons do not 279 
advocate the routine use of intraoperative drain which was found to be in keeping with a 280 
review of 353 patients of SG that found no benefit with intraabdominal drains in terms of 281 
detection of leak, abscess, bleeding or reoperation due to these complications [34]. 282 
A limitation of this study is that in spite of the large number of surgeons who participated 283 
from different countries, there is a possibility of missing out on bariatric surgeons who have 284 
not participated in the survey. However, the aim of this survey was to get a worldwide 285 
snapshot of the prevailing practices concerning SG and the authors believe that this was 286 
accomplished based on the large number of participating surgeons from 67 countries. 287 
Another limitation is that because of our methodology, we are not able to give an exact 288 
response rate but we believe our sample is representative because of the large number of 289 
surgeons who participated in the survey from all parts of the world in this very narrow 290 
surgical specialty. Certain intraoperative factors like the snugness of the stapler to the 291 
orogastric tube and the method of measurement of the distance between the pylorus and 292 
beginning of gastric transection were not addressed in this survey.  293 
Finally, authors would like to caution against over interpretation of this data. The purpose of 294 
this study is simply to capture global variation and not to identify best practice as that can 295 
only be done through adequately designed scientific studies. In that sense, even a variation 296 
practiced by the majority may not be the scientifically correct choice and should be examined 297 
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in future studies. At the same time, knowing the variations might make it easier to design 298 
future studies to identify best practice and future attempts at consensus building while we 299 





















This study found significant variation amongst global community of bariatric surgeons with 319 
regards to various perioperative practices concerning SG and identifies areas for future 320 
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FIGURE LEGENDS 442 
Figure 1. Size of orogastric tube in sleeve gastrectomy preferred by the participants of the 443 
survey (n=856). 444 
Figure 2. Distance from the pylorus at the beginning of gastric transection preferred by the 445 
































Table 1: Survey questionnaire with summary of responses (Edited) 476 
 477 
Questions Responses 
Please confirm that you are a bariatric 
surgeon already performing SG 




No, I do not 
perform SG 
No, I am not 
a bariatric 
surgeon 
Which country do you work In? Data summarised in Table 2 
How many SG procedures have you 
personally performed till date? 
 
Please mention the exact number of SG 
procedures you have personally performed 
till date? 
 
Are there any absolute contraindications to 
SG in your practice? Please list them 
Data summarised in Table 3 
Are there any relative contraindications to 
SG in your practice? Please list them 
Data summarised in Table 4 
Do you routinely perform a preoperative 
upper gastrointestinal endoscopy? 
Yes No 
Do you routinely perform a preoperative 
Ultrasound scan of the abdomen? 
Yes No 
Do you always use an orogastric tube to 
size the sleeve? 
Yes No 
If the answer to the last question is "Yes", 
please provide us with the size of the 
orogastric tube you use? 
Data summarised in Figure 1 
How far from the pylorus do you start while 
fashioning the sleeve? 
Data summarised in Figure 2 
Do you routinely dissect the hiatus to 
diagnose occult hiatus hernia? 
Yes No 
Do you routinely approximate the 
diaphragmatic crura in patients with 





Do you routinely use staple line 
reinforcement? 
Yes No 
If the answer to the last question is "Yes", 
please let us know what form of staple line 
reinforcement you use. 
Data summarised in Table 5 
Do you place ligaclips on splenic side of 
short gastric vessels before dividing them 
using energy device? 
Yes No 
Do you routinely anchor the omentum to 
the sleeve at the end of the procedure? 
Yes No 
Do you routinely perform an intraoperative 
upper gastrointestinal endoscopy? 
Yes No 
Do you routinely perform a leak test after 
sleeve gastrectomy? 
Yes No 
If the answer to the last question is "Yes", 
please mention the technique you use. 
Data summarised in Table 6 
Do you routinely leave an intra-abdominal 
drain? 
Yes No 
Do you perform robotic sleeve 
gastrectomy? 
Yes No 
Do you perform single port sleeve 
gastrectomy? 
Yes No 
Do you routinely carry out contrast study in 
the early postoperative period? 
Yes No 
Please describe when you start oral intake 
for your patients postoperatively. 
 
Do you recommend lifelong 
multivitamin/mineral supplements after 
sleeve gastrectomy? 
Yes No 
Do you recommend lifelong additional iron 
supplements? 
Yes No 
Do you routinely recommend lifelong Yes No 
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additional Vitamin D supplements? 
Do you routinely recommend lifelong 
additional Vitamin B12 supplements? 
Yes No 
Do you routinely recommend lifelong 
additional calcium supplements? 
Yes No 
Do you routinely use PPI prophylaxis after 
SG? 
Yes No 
Do you routinely use Ursodeoxycholic acid 
for prophylaxis of gall stones? 
Yes No 
What is your preferred procedure for 
patients seeking revisional bariatric 
procedure for further weight loss or co-
morbidity resolution after SG? 
 
What is your preferred procedure for 
patients presenting with symptoms of 
GORD unresponsive to medical 
management after SG? 
 



















     Table 2: Country of origin of the survey participants in alphabetical order. 492 




Argentina 24 2.78% 
Australia 20 2.32% 
Austria 4 0.46% 
Azerbaijan 2 0.23% 
Bahrain 1 0.12% 
Belgium 12 1.39% 
Bolivia 4 0.46% 
Brazil 65 7.53% 
Canada 3 0.35% 
Chile 15 1.74% 
China 9 1.04% 
Colombia 17 1.97% 
Costa Rica 3 0.35% 
Czech Republic 5 0.58% 
Dominican Republic 4 0.46% 
Ecuador 1 0.12% 
Egypt 20 2.32% 
France 37 4.29% 
Germany 18 2.09% 
Greece 7 0.81% 
Guatemala 1 0.12% 
Iceland 1 0.12% 
India 56 6.49% 
Indonesia 2 0.23% 
Iran 10 1.16% 
Ireland 3 0.35% 
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Israel 4 0.46% 
Italy 43 4.98% 
Japan 3 0.35% 
Jordan 4 0.46% 
Kazakhstan 1 0.12% 
Kuwait 5 0.58% 
Lebanon 11 1.27% 
Malaysia 5 0.58% 
Mexico 46 5.33% 
Netherlands 16 1.85% 
New Zealand 1 0.12% 
Nicaragua 3 0.35% 
Norway 3 0.35% 
Oman 4 0.46% 
Pakistan 9 1.04% 
Paraguay 4 0.46% 
Peru 3 0.35% 
Philippines 5 0.58% 
Poland 6 0.7% 
Portugal 9 1.04% 
Republic of Korea 4 0.46% 
Romania 2 0.23% 
Russian Federation 7 0.81% 
Saudi Arabia 24 2.78% 
Singapore 8 0.93% 
Slovenia 2 0.23% 
Spain 44 5.1% 
Sudan 1 0.12% 
Swaziland 1 0.12% 
Sweden 7 0.81% 
Switzerland 2 0.23% 



































Taiwan 3 0.35% 
Tunisia 1 0.12% 
Turkey 15 1.74% 
Ukraine 1 0.12% 
United Arab Emirates 26 3.01% 
United Kingdom 71 8.23% 
United States of America 105 12.17% 
Uruguay 1 0.12% 
Venezuela 5 0.58% 
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Table 3: Absolute contraindications to sleeve gastrectomy as reported by the 525 
participants of the survey. 526 
 527 
 528 
GERD, Gastro-esophageal Reflux Disease; PPI, Proton Pump Inhibitor; BMI, Body Mass 529 
Index 530 
 531 




Anatomical and Physiological Absolute Contraindications 
Barrett’s Esophagus 683 79.14% 
Hiatus Hernia (irrespective of size) 85 9.85% 
Moderate (2.0-4.0 cm) and Large 
(>4.0 cm) Hiatus Hernia 
159 18.42% 
Large (>4.0 cm) Hiatus Hernia only 347 40.21% 
GERD (irrespective of severity) 198 22.94% 
Severe GERD (needing daily PPI 
therapy) 
486 56.32% 
Weight-related Absolute Contraindications 
BMI > 50.0 39 4.52% 
BMI > 45.0 16 1.85% 
BMI > 40.0 9 1.04% 
Co-morbidity related Absolute Contraindications 
Diabetes Mellitus (irrespective of 
severity or duration) 
28 3.24% 
Uncontrolled Diabetes Mellitus 128 14.83% 
Insulin Dependent Diabetes 
Mellitus 
71 8.23% 
Cirrhosis of Liver 138 15.99% 
Miscellaneous Absolute Contraindications 
Other 68 7.88% 
No Absolute Contraindications 
No Absolute Contraindications 106 12.28% 
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Table 4: Relative contraindications to sleeve gastrectomy as reported by the 532 
participants of the survey. 533 
 534 




Anatomical and Physiological Relative Contraindications 
Barrett’s Oesophagus 243 28.16% 
Hiatus Hernia (irrespective of size) 172 11.93% 
Moderate (2.0-4.0 cm) and Large 
(>4.0 cm) Hiatus Hernia 
220 25.49% 
Large (>4.0 cm) Hiatus Hernia only 254 29.43% 
GERD (irrespective of severity) 295 34.18% 
Severe GERD (needing daily PPI 
therapy) 
289 33.49% 
Weight-related Relative Contraindications 
BMI > 50.0 106 12.28% 
BMI > 45.0 36 4.17% 
BMI > 40.0 16 1.85% 
Co-morbidity related Relative Contraindications 
Diabetes Mellitus (irrespective of 
severity or duration) 
106 12.28% 
Uncontrolled Diabetes Mellitus 221 25.61% 
Insulin Dependent Diabetes 
Mellitus 
140 16.22% 
Cirrhosis of Liver 155 17.96% 
Miscellaneous Relative Contraindications 
Other 35 4.06% 
No Relative Contraindications 
No Absolute Contraindications 64 7.42% 






Table 5: Type of staple line reinforcement in sleeve gastrectomy preferred by the 539 





























Oversewing with running suture 208 24.10% 
SeamguardTM 149 17.26% 
Invagination with running suture 84 9.73% 
MedtronicTM Reinforced Staples 73 8.46% 
PeristripsTM 27 5.38% 
Fibrin sealant 23 3.12% 
Other 35 6.97% 
No Reinforcement 334 38.70% 
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Table 6: Technique of intraoperative leak test in sleeve gastrectomy preferred by the 563 











Dilute Methylene Blue Solution 458 53.07% 
Air insufflation using orogastric tube 84 9.73% 
Air insufflation using an endoscope 69 7.99% 
Other 131 15.19% 
No intraoperative leak test 121 14.02% 
